Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 109 P246 | DOI: 10.1530/endoabs.109.P246

SFEBES2025 Poster Presentations Thyroid (41 abstracts)

Familial polyglandular deficiencies with no AIRE mutation: random occurrence or genetic predisposition yet to be discovered?

Zaiem Zarkasi 1 , Rajshekhar Mudaliar 1 & Akheel A. Syed 1,2


1Endocrinology, Salford Royal Hospital, Northern Care Alliance Foundation Trust, Salford, United Kingdom; 2Faculty of Biology, Medicine and Health, University of Manchester, Salford, United Kingdom


Autoimmune Polyglandular Syndromes (APS) are rare disorders characterised by immune-mediated multi-organ dysfunctions. The three main subtypes, APS-1, APS-2, and APS-3 are distinguished by different patterns of endocrine involvement. Mutations in the autoimmune regulator (AIRE) gene on chromosome 21q22.3 that impair thymic immune tolerance causes APS-1, which is strongly associated with autoimmune hypoparathyroidism (90% of cases), chronic mucocutaneous candidiasis and adrenal insufficiency. It can also involve type 1 diabetes, hypothyroidism, pernicious anaemia, vitiligo, hepatitis, oophoritis and keratitis. Recent evidence suggests that existing diagnostic criteria may be inadequate, as not all patients with APS-1 exhibit classical features. We present a woman (index case) with chronic hypocalcaemia due to hypoparathyroidism since birth, type 1 diabetes from age 10 years and autoimmune hypothyroidism in her forties. Her younger sister also has chronic hypoparathyroidism with hypocalcaemia, and hypothyroidism. There is a family history of thyroid dysfunction in another sister, a brother, and their mother. These findings suggest a potential hereditary polyglandular deficiency pattern that does not fully fit the diagnosis of APS-1. It raises the possibility of either a non-classical/variant form of the syndrome, an unidentified gene mutation or a different type of polyglandular syndrome which is yet to be classified. It underscores the heterogeneity of APS, revealing gaps in our understanding of its genetic and phenotypic spectrum.

Laboratory results:
PTH (2.0 - 9.3) pmol/LParathyroid AntibodiesAdjusted calcium (2.20 - 2.60) mmol/L*Urinary calcium Excretion Index (0.013 - 0.037) mmol/LVitamin D (50.0 - 125.0) nmol/LThyroid Peroxidase Antibody (< 35) IU/mLIslet Cell AntibodyAnti-GAD antibody (< 5.0) U/mLAIRE gene mutation
Index case1.2 -3Negative1.86 - 2.190.05279 - 99.6> 1000Positive> 2000Absent
Sibling case1.5 - 3.2Not tested2.08 - 2.190.04155.6 - 96.915 (< 35)N/AN/AAwaited
*Prior to endocrine review. N/A, not applicable

Volume 109

Society for Endocrinology BES 2025

Harrogate, UK
10 Mar 2025 - 12 Mar 2025

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches